FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1551389275> ?p ?o ?g. }

• W1551389275 endingPage "1238" @default.
• W1551389275 startingPage "1228" @default.
• W1551389275 abstract "The critical role of blood supply in the growth of solid tumours makes blood vessels an ideal target for anti-tumour drug discovery. The anti-angiogenic and vascular disrupting activities of C9, a newly synthesized microtubule-depolymerizing agent, were investigated with several in vitro and in vivo models. Possible mechanisms involved in its activity were also assessed.Microtubule-depolymerizing actions were assessed by surface plasmon resonance binding, competitive inhibition and cytoskeleton immunofluorescence. Anti-angiogenic and vascular disrupting activities were tested on proliferation, migration, tube formation with human umbilical vein endothelial cells, and in rat aortic ring, chick chorioallantoic membrane and Matrigel plug assays. Western blots and Rho activation assays were employed to examine the role of Raf-MEK-ERK (mitogen-activated ERK kinase, extracellular signal-regulated kinase) and Rho/Rho kinase signalling.C9 inhibited proliferation, migration and tube formation of endothelial cells and inhibited angiogenesis in aortic ring and chick chorioallantoic membrane assays. C9 induced disassembly of microtubules in endothelial cells and down-regulated Raf-MEK-ERK signalling activated by pro-angiogenic factors. In addition, C9 disrupted capillary-like networks and newly formed vessels in vitro and rapidly decreased perfusion of neovasculature in vivo. Endothelial cell contraction and membrane blebbing induced by C9 in neovasculature was dependent on the Rho/Rho kinase pathway.Anti-angiogenic and vascular disruption by C9 was associated with changes in morphology and function of endothelial cells, involving the Raf-MEK-ERK and Rho/Rho kinase signalling pathways. These findings strongly suggest that C9 is a new microtubule-binding agent that could effectively target tumour vasculature." @default.
• W1551389275 created "2016-06-24" @default.
• W1551389275 creator A5009196583 @default.
• W1551389275 creator A5034965904 @default.
• W1551389275 creator A5040018415 @default.
• W1551389275 creator A5082378480 @default.
• W1551389275 creator A5089348951 @default.
• W1551389275 date "2009-04-01" @default.
• W1551389275 modified "2023-10-17" @default.
• W1551389275 title "Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent" @default.
• W1551389275 cites W1964556827 @default.
• W1551389275 cites W197509391 @default.
• W1551389275 cites W1978139448 @default.
• W1551389275 cites W1982103277 @default.
• W1551389275 cites W1988202409 @default.
• W1551389275 cites W1991123816 @default.
• W1551389275 cites W1995121627 @default.
• W1551389275 cites W2005747992 @default.
• W1551389275 cites W2015809080 @default.
• W1551389275 cites W2023115975 @default.
• W1551389275 cites W2029852728 @default.
• W1551389275 cites W2039138706 @default.
• W1551389275 cites W2042100002 @default.
• W1551389275 cites W2047578735 @default.
• W1551389275 cites W2056637878 @default.
• W1551389275 cites W2058065405 @default.
• W1551389275 cites W2064571598 @default.
• W1551389275 cites W2073880616 @default.
• W1551389275 cites W2077391174 @default.
• W1551389275 cites W2084740377 @default.
• W1551389275 cites W2090852550 @default.
• W1551389275 cites W2113101214 @default.
• W1551389275 cites W2128773741 @default.
• W1551389275 cites W2130172628 @default.
• W1551389275 cites W2134634408 @default.
• W1551389275 cites W2139213909 @default.
• W1551389275 cites W2148990197 @default.
• W1551389275 cites W2152574565 @default.
• W1551389275 cites W2157111798 @default.
• W1551389275 cites W2157603347 @default.
• W1551389275 cites W2165629556 @default.
• W1551389275 cites W2166435019 @default.
• W1551389275 cites W2324677651 @default.
• W1551389275 cites W2793323124 @default.
• W1551389275 cites W4253705647 @default.
• W1551389275 doi "https://doi.org/10.1111/j.1476-5381.2009.00112.x" @default.
• W1551389275 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2697741" @default.
• W1551389275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19302593" @default.
• W1551389275 hasPublicationYear "2009" @default.
• W1551389275 type Work @default.
• W1551389275 sameAs 1551389275 @default.
• W1551389275 citedByCount "33" @default.
• W1551389275 countsByYear W15513892752012 @default.
• W1551389275 countsByYear W15513892752013 @default.
• W1551389275 countsByYear W15513892752014 @default.
• W1551389275 countsByYear W15513892752015 @default.
• W1551389275 countsByYear W15513892752016 @default.
• W1551389275 countsByYear W15513892752018 @default.
• W1551389275 countsByYear W15513892752019 @default.
• W1551389275 countsByYear W15513892752020 @default.
• W1551389275 countsByYear W15513892752021 @default.
• W1551389275 countsByYear W15513892752022 @default.
• W1551389275 crossrefType "journal-article" @default.
• W1551389275 hasAuthorship W1551389275A5009196583 @default.
• W1551389275 hasAuthorship W1551389275A5034965904 @default.
• W1551389275 hasAuthorship W1551389275A5040018415 @default.
• W1551389275 hasAuthorship W1551389275A5082378480 @default.
• W1551389275 hasAuthorship W1551389275A5089348951 @default.
• W1551389275 hasBestOaLocation W15513892751 @default.
• W1551389275 hasConcept C123012128 @default.
• W1551389275 hasConcept C142669718 @default.
• W1551389275 hasConcept C1491633281 @default.
• W1551389275 hasConcept C184235292 @default.
• W1551389275 hasConcept C201800478 @default.
• W1551389275 hasConcept C202751555 @default.
• W1551389275 hasConcept C20418707 @default.
• W1551389275 hasConcept C2778608917 @default.
• W1551389275 hasConcept C2780394083 @default.
• W1551389275 hasConcept C502942594 @default.
• W1551389275 hasConcept C55493867 @default.
• W1551389275 hasConcept C57074206 @default.
• W1551389275 hasConcept C86803240 @default.
• W1551389275 hasConcept C95444343 @default.
• W1551389275 hasConceptScore W1551389275C123012128 @default.
• W1551389275 hasConceptScore W1551389275C142669718 @default.
• W1551389275 hasConceptScore W1551389275C1491633281 @default.
• W1551389275 hasConceptScore W1551389275C184235292 @default.
• W1551389275 hasConceptScore W1551389275C201800478 @default.
• W1551389275 hasConceptScore W1551389275C202751555 @default.
• W1551389275 hasConceptScore W1551389275C20418707 @default.
• W1551389275 hasConceptScore W1551389275C2778608917 @default.
• W1551389275 hasConceptScore W1551389275C2780394083 @default.
• W1551389275 hasConceptScore W1551389275C502942594 @default.
• W1551389275 hasConceptScore W1551389275C55493867 @default.
• W1551389275 hasConceptScore W1551389275C57074206 @default.
• W1551389275 hasConceptScore W1551389275C86803240 @default.
• W1551389275 hasConceptScore W1551389275C95444343 @default.
• W1551389275 hasIssue "8" @default.

• next